Historeceptomics Profiling of Ketamine

Ketamine elicits distinctive neuropsychiatric phenotypes from a complex and as yet elusive mechanism of action. Here, we applied an updated Historeceptomics approach to identify molecular targets and brain tissues that may contribute to its antidepressant, analgesic, and dissociative effects. Historeceptomics generates multidimensional target-tissue fingerprints by integrating drug-target activity with tissue-specific target expression, providing an anatomic profile of drug action. The results suggest that ketamine activity on NMDA receptors in the prefrontal and cingulate cortices and the amygdala may contribute to ketamine improvements in social functioning for MDD. However, this same receptor-tissue activity may invoke hallucinatory effects at higher intensity or with engagement of additional brain regions. The central nervous system (CNS) fingerprint for ketamine was compared with those of other psychoactive drugs, showing overlap with fingerprints from other antidepressant, hallucinogenic, and analgesic drugs. Some ketamine effects may be traced to specific enantiomers or metabolites of ketamine. These findings provide new insights into the mechanisms by which ketamine elicits its unique phenotype and demonstrate the utility of using Historeceptomics to understand complex drug action.

Authors

Institutions

Publication Details

Journal
bioRxiv (Cold Spring Harbor Laboratory)
Published
2026-11-19
DOI
https://doi.org/10.64898/2026.11.18.767642
Primary Topic
Treatment of Major Depression
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Historeceptomics Profiling of Ketamine

Eric H. Rosenn, Timothy J. Cardozo, Jennifer A. Fuller, Harrison Agnor
bioRxiv (Cold Spring Harbor Laboratory)
Treatment of Major Depression
preprint

Historeceptomics Profiling of Ketamine

Eric H. Rosenn, Timothy J. Cardozo, Jennifer A. Fuller, Harrison Agnor
preprint en

Abstract

Ketamine elicits distinctive neuropsychiatric phenotypes from a complex and as yet elusive mechanism of action. Here, we applied an updated Historeceptomics approach to identify molecular targets and brain tissues that may contribute to its antidepressant, analgesic, and dissociative effects. Historeceptomics generates multidimensional target-tissue fingerprints by integrating drug-target activity with tissue-specific target expression, providing an anatomic profile of drug action. The results suggest that ketamine activity on NMDA receptors in the prefrontal and cingulate cortices and the amygdala may contribute to ketamine improvements in social functioning for MDD. However, this same receptor-tissue activity may invoke hallucinatory effects at higher intensity or with engagement of additional brain regions. The central nervous system (CNS) fingerprint for ketamine was compared with those of other psychoactive drugs, showing overlap with fingerprints from other antidepressant, hallucinogenic, and analgesic drugs. Some ketamine effects may be traced to specific enantiomers or metabolites of ketamine. These findings provide new insights into the mechanisms by which ketamine elicits its unique phenotype and demonstrate the utility of using Historeceptomics to understand complex drug action.

bioRxiv (Cold Spring Harbor Laboratory)
NYU Langone Health (US), New York University (US)
Treatment of Major Depression
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon